Ïã¸ÛÁùºÏ²ÊÖ±²¥¿ª½±

Overview

BSR's 'gold standard' clinical guidelines support evidence-based clinical practice in Ïã¸ÛÁùºÏ²ÊÖ±²¥¿ª½±.

Our guidelines are developed using the methods and processes outlined in Creating Clinical Guidelines: Ïã¸ÛÁùºÏ²ÊÖ±²¥¿ª½± Protocol and overseen by our Guidelines Steering Group.

Our guidelines grow out of the collaborative efforts of many members and non-members, specialists and generalists and people with lived experience of the topic being covered. We also involve trainees in our guideline working groups as an important educational opportunity.

All guidelines are published in Rheumatology under an ‘open access’ licence.

To develop our guidelines, we partner with the University of Keele to support the evidence review process.
NICE provided accreditation for our clinical guideline development process up until NICE accreditation was no longer available, at the end of 2023.

Our guidelines grow out of the collaborative efforts of many members and non-members, specialists and generalists and people with lived experience of the topic being covered. We also involve trainees in our guideline working groups as an important educational opportunity.

Listen to our recent podcast episode with guideline working group members for tips on applying to join.

 

 

NICE accreditation logo
Get involved

Get involved in our guidelines

Get in touch

Pregnancy and breastfeeding: Part 1

Guideline on prescribing drugs in pregnancy and breastfeeding Part 1: immunomodulatory anti-rheumatic drugs and corticosteroids. 


2022 NICE-accredited

Audit tool

 

Pregnancy and breastfeeding: Part 2

Guideline on prescribing drugs in pregnancy and breastfeeding Part 2: comorbidity medications used in Ïã¸ÛÁùºÏ²ÊÖ±²¥¿ª½± practice. 


2022 NICE-accredited

Audit tool

PsA with biologics/DMARDs

Guideline for the treatment of psoriatic arthritis with biologics and targeted synthetic DMARDs. 2022 NICE-accredited.


Audit tool

Summary cheat sheet

Summary algorithm slide

Paediatric, adolescent and adult patients with idiopathic inflammatory myopathy (myositis)

Guideline for the management of paediatric, adolescent and adult patients with idiopathic inflammatory myopathy (myositis). 2022 NICE-accredited.

Audit tool

Sjögren disease

Guideline for the management of adult and juvenile onset Sjögren disease.

2023 NICE-accredited.

Summary sheet
Audit tool



Gout

Guideline for the management of gout. 2017 NICE-accredited. Currently being considered for revision.

Audit tool

  


Gout guideline blog

Giant cell arteritis

Guideline on the management of patients with giant cell arteritis. 2020 NICE-accredited. Revision will be considered in 2024.

Audit tool


Hot swollen joint - paediatric and adolescent

Guideline for the management of hot swollen joint in paediatric and adolescent patients.

Interstitial lung disease (ILD)

Diagnosis and management of systemic autoimmune rheumatic disease-associated interstitial lung disease.

Pain management in people with inflammatory arthritis

Management of pain in paediatric, adolescent, and adult patients with inflammatory arthritis.

Foot health in inflammatory arthritis

Management of foot health in patients with inflammatory arthritis. 


Hot swollen joint

Guideline for management of hot swollen joint in adults. 2006. In revision.

Hot Joint guideline update


DMARDs

Guideline for the prescription and monitoring of non-biologic disease-modifying anti-rheumatic drugs. 2017 NICE-accredited. In revision.

Audit tool


ANCA-associated vasculitis

Guideline for the management of adults with ANCA-associated vasculitis. 2014. Currently being considered for revision.


Lupus

Guideline for the management of adults with Systemic Lupus Erythematosus. 2017 NICE-accredited. In revision.


2017 guideline

Audit tool


Systemic sclerosis

Guideline for the treatment of systemic sclerosis. 2016 NICE-accredited. In revision.

2016 guideline

Audit (See page 10 of the full GL for guidance on audit)

Biological DMARD safety

Guideline for the safe prescribing of biologics in adults with inflammatory arthritis. 2019 NICE-accredited. In revision.

Executive summary


Polymyalgia rheumatica

Guideline for the treatment of polymyalgia rheumatica. In revision.

2009 guideline


Axial spondyloarthritis

Guideline for the treatment of axial spondyloarthritis (including ankylosing spondylitis) with biologics. 2016 NICE-accredited. In revision.

2016 guideline


Audit tool


Implementing guidelines

We want to hear your experiences of using the guidelines to help us spot patterns, create case studies and find solutions to problems.

How has care in your unit improved through implementation? What clinical issues have you resolved by using a guideline? Are you or your unit having problems implementing any part of the guidelines?

If there is anything else you would like to share with us about planning, creating, auditing or using the guidelines, please email guidelines@Ïã¸ÛÁùºÏ²ÊÖ±²¥¿ª½±.org.uk.